P3 Health Partners (PIII) EBIT Margin (2021 - 2025)

P3 Health Partners (PIII) has reported EBIT Margin for 5 consecutive years, with 39.98% the latest figure, recorded in Q4 2025.

• EBIT Margin for Q4 2025 came in at 39.98%, down 262.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 18.53% (up 285.0% YoY), and the FY2025 annual result was 18.53%, up 285.0% from the prior year.
• EBIT Margin was 39.98% for Q4 2025 at P3 Health Partners, down from 12.81% in the prior quarter.
• Over five years, EBIT Margin peaked at 258.96% in Q4 2021 and troughed at 848.83% in Q1 2021.
• Average EBIT Margin over 5 years is 71.36%, with a median of 17.98% recorded in 2021.
• The widest YoY moves for EBIT Margin: up 82975 bps in 2022, down 32057 bps in 2022.
• Over 5 years, EBIT Margin stood at 258.96% in 2021, then tumbled by 180 bps to 207.79% in 2022, then jumped by 91 bps to 18.53% in 2023, then sank by 102 bps to 37.36% in 2024, then slipped by 7 bps to 39.98% in 2025.
• Per Business Quant data, the three most recent EBIT Margin figures were 39.98% in Q4 2025, 12.81% in Q3 2025, and 9.59% in Q2 2025.